SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cardium Therapeutics angiogenesis bio-assay
An SI Board Since August 2012
Posts SubjectMarks Bans Symbol
0 0 0 CXM
Emcee:  SanDiegoBiotech Type:  Moderated
Introduction Market Data Compact
Cardium Therapeutics (CXM) has taken another step toward commercializing its Generx gene therapy for heart disease with newly developed bio-assay and process technology.

sandiegobiotechnology.com
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News